What are the reported side effects of Kisspeptin-10?

Reported side effects of Kisspeptin-10 include: Generally well-tolerated in clinical trials, Nausea (mild, uncommon), Potential for over-stimulation of the HPG axis at high doses (rarely significant), Theoretical desensitization with continuous (non-pulsatile) dosing, Flushing.

Performance

Kisspeptin-10

Q: What is the dosing range for Kisspeptin-10?

Kisspeptin-10 is typically dosed at 50mcg (low), 100mcg (moderate), or 250mcg (high) mcg, administered 1–2x daily (pulsatile administration is important — avoid continuous infusion). These ranges are aggregated from preclinical research and community protocols — not medical dosing guidance.

Also known as: KP-10, Metastin(112-121), KISS1R agonist

Kisspeptin-10 is a research compound. Kisspeptin analogs are under active clinical investigation for fertility treatment but are not currently FDA-approved. For informational purposes only.

📚 Content aggregated from:3 peer-reviewed sources·r/Peptides community·PubMed / NCBI

Overview

Kisspeptin-10 is the biologically active 10-amino acid C-terminal fragment of kisspeptin, a neuropeptide that acts as the master regulator of the hypothalamic-pituitary-gonadal (HPG) axis. By activating KISS1R (GPR54) in the hypothalamus, it triggers pulsatile GnRH release, which drives LH, FSH, and downstream testosterone and estrogen production. It is the upstream signal that 'turns on' the reproductive axis — with research applications spanning fertility, hypogonadism, post-cycle therapy support, and age-related hormonal decline.

Research Summary

Kisspeptin neurons in the arcuate nucleus form the pulse generator for GnRH secretion — without kisspeptin signaling, reproductive function ceases. Human clinical trials confirm that IV kisspeptin-10 produces rapid, dose-dependent LH pulses in both males and females, restoring hormonal function in hypogonadotropic hypogonadism. Kisspeptin-54 (the longer form) has been studied in human fertility treatments with successful outcomes. Unlike direct LH/FSH administration, kisspeptin works upstream at the hypothalamus, preserving the natural pulsatile release pattern and avoiding receptor desensitization associated with continuous GnRH agonists.

Dosing Range

low

50mcg

moderate

100mcg

high

250mcg

Units: mcg · Frequency: 1–2x daily (pulsatile administration is important — avoid continuous infusion)

Dosing ranges are aggregated from preclinical research and community protocols. Not medical dosing guidance.

Administration Routes

Subcutaneous injectionIntranasalIntravenous (clinical studies — produces most reliable LH pulses)

Reconstitution Notes

Reconstitute with bacteriostatic water to 1mg/mL. Pulsatile administration is critical — continuous kisspeptin suppresses GnRH rather than stimulating it (similar to GnRH agonist paradox). Subcutaneous once or twice daily mimics physiological pulsatility adequately. Stable 28 days refrigerated.

Step-by-step reconstitution guide →

Supplies you'll need

Insulin Syringes (U-100)Reconstitution Needles Lambda BAC Water Alcohol Prep Pads

Affiliate links — Research Stack may earn a small commission at no extra cost to you.

Reported Side Effects

Generally well-tolerated in clinical trials
Nausea (mild, uncommon)
Potential for over-stimulation of the HPG axis at high doses (rarely significant)
Theoretical desensitization with continuous (non-pulsatile) dosing
Flushing

Research Papers

3 peer-reviewed sources

Kisspeptin-10 is a potent stimulator of LH release in healthy young men

Journal of Clinical Endocrinology & Metabolism2005

Intravenous kisspeptin-54 stimulates gonadotropin secretion in women with hypothalamic amenorrhea

Journal of Clinical Endocrinology & Metabolism2007

Kisspeptin signaling and the control of GnRH pulse generation

Endocrinology2010

Community Experiences

Aggregated from public forums. Anecdotal — not clinical evidence.

r/Peptides

Community protocols using kisspeptin-10 for natural testosterone restoration, PCT support, and fertility.

View original thread

r/steroids

Community discussion on kisspeptin for post-cycle therapy as an upstream HPG axis restart mechanism.

View original thread

Overview

Kisspeptin is the "master switch" of the reproductive axis. Located in the hypothalamic arcuate nucleus, kisspeptin neurons receive signals about energy status, stress, photoperiod, and steroid feedback — integrating all of these to decide whether to pulse GnRH or not. Without kisspeptin signaling, the entire HPG cascade stops.

This makes kisspeptin-10 uniquely positioned: it restores hormonal function by working at the top of the axis, triggering natural pulsatile GnRH release rather than directly injecting LH or testosterone.

The HPG Axis Cascade

Kisspeptin → GnRH → LH + FSH → Testosterone / Estradiol

Each step is amplified: a small kisspeptin pulse triggers a larger GnRH pulse, which triggers an even larger LH pulse, which then drives testosterone synthesis. This cascade leverage means low doses of kisspeptin produce significant downstream hormonal responses.

Why Pulsatility Matters

The reproductive axis is critically dependent on pulsatile rather than continuous GnRH signaling:

Pulsatile GnRH: Maintains LH/FSH production → normal testosterone
Continuous GnRH: Desensitizes pituitary receptors → LH/FSH suppression → testosterone crash

This is exactly how GnRH agonists (Lupron, Synarel) work for prostate cancer and endometriosis — continuous administration paradoxically suppresses the axis.

Kisspeptin administered once or twice daily mimics pulsatile physiology, preserving the stimulatory response. This is the critical dosing insight: do not administer kisspeptin continuously.

Post-Cycle and Hypogonadism Applications

After anabolic steroid or GH cycle, the HPG axis is suppressed at the hypothalamic level — the arcuate nucleus kisspeptin neurons reduce pulsing due to negative feedback from exogenous androgens. Recovery requires re-sensitization of this system.

Kisspeptin-10 targets this exact failure point — it directly reactivates the GnRH pulse generator, upstream of clomiphene (which works at the pituitary) and Nolvadex (which works at the pituitary/hypothalamus via estrogen receptor blockade).

Clinical Use — Fertility

Kisspeptin-54 (the longer, more stable form) has been used in human IVF protocols to trigger final oocyte maturation — with clinical outcomes comparable to standard hCG trigger shots but with significantly lower risk of ovarian hyperstimulation syndrome (OHSS). This is now a registered clinical use in some centers.